Cargando…
A simple and robust reporter gene assay for measuring the bioactivity of anti-RANKL therapeutic antibodies
RANKL (receptor activator of nuclear factor κB ligand) plays a key role in the differentiation, activation and survival of osteoclasts. Denosumab, which targets RANKL, is approved for osteoporosis or bone loss that has a high risk for fracture and bone metastases from solid tumors. Bioactivity deter...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal Society of Chemistry
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076180/ https://www.ncbi.nlm.nih.gov/pubmed/35542634 http://dx.doi.org/10.1039/c9ra07328k |